Gastrointestinal and Other Cancers Clinical Trials
Title |
Intervention | NCT ID | Sponsor | Status |
|---|---|---|---|---|
| Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer | Genistein, Laboratory Biomarker Analysis, Pharmacological Study, Placebo Administration, Therapeutic Conventional Surgery | NCT00118040 | National Cancer Institute (NCI) | Active, not recruiting |
| Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis | Laboratory Biomarker Analysis, Questionnaire Administration, Simvastatin, Placebo Administration | NCT02968810 | National Cancer Institute (NCI) | Recruiting |
| Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis | Laboratory Biomarker Analysis, Placebo, Quality-of-Life Assessment, Questionnaire Administration, Simvastatin | NCT02743364 | National Cancer Institute (NCI) | Active, not recruiting |
| Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps | Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine, Quality-of-Life Assessment, Saline | NCT02134925 | National Cancer Institute (NCI) | Active, not recruiting |